» Articles » PMID: 37599536

Longitudinal Changes in Neuropsychological Functioning in Japanese Patients with Myotonic Dystrophy Type 1: A Five Year Follow-Up Study

Overview
Publisher Sage Publications
Specialty Neurology
Date 2023 Aug 21
PMID 37599536
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myotonic dystrophy type 1 (DM1) is a form of muscular dystrophy that causes various symptoms, including those of the central nervous system. Some studies have reported cognitive decline in patients with DM1, although the available evidence is limited.

Objective: This study aimed to describe longitudinal differences in neuropsychological function in patients with DM1.

Methods: A total of 66 Japanese adult patients with DM1 were investigated using a neuropsychological battery to assess several cognitive domains, including memory, processing speed, and executive function. The patients underwent neuropsychological evaluation approximately five years after baseline (Times 1 and 2).

Results: Thirty-eight patients underwent a second neuropsychological evaluation. The participants in the Time 2 evaluation were younger than those who did not participate in Time 2. Patients showed a decline in the Mini-Mental State Examination, Trail Making Test (TMT), Block Design, and Symbol Digit Modalities Test at Time 2 (P < 0.05). Age at Time 1 was associated with a decline in TMT-A and TMT-B scores (rho = 0.57 and 0.45, respectively).

Conclusion: These results suggest a cognitive decline in patients with DM1 and warrant further investigation into the possible effects of age-related changes.

Citing Articles

Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles.

Davion J, Tard C, Fragoso L, Wilu-Wilu A, Skrobala E, Defebvre L J Neurol. 2024; 271(7):4529-4539.

PMID: 38709306 DOI: 10.1007/s00415-024-12404-2.


Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review.

Wu Y, Wei Q, Lin J, Shang H, Ou R Front Cell Neurosci. 2024; 18:1369332.

PMID: 38638300 PMC: 11024338. DOI: 10.3389/fncel.2024.1369332.

References
1.
Wahbi K, Porcher R, Laforet P, Fayssoil A, Becane H, Lazarus A . Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1. JAMA Neurol. 2018; 75(5):573-581. PMC: 5885178. DOI: 10.1001/jamaneurol.2017.4778. View

2.
Takegami M, Suzukamo Y, Wakita T, Noguchi H, Chin K, Kadotani H . Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory. Sleep Med. 2008; 10(5):556-65. DOI: 10.1016/j.sleep.2008.04.015. View

3.
Cabada T, Iridoy M, Jerico I, Lecumberri P, Seijas R, Gargallo A . Brain Involvement in Myotonic Dystrophy Type 1: A Morphometric and Diffusion Tensor Imaging Study with Neuropsychological Correlation. Arch Clin Neuropsychol. 2017; 32(4):401-412. DOI: 10.1093/arclin/acx008. View

4.
Fujino H, Saito T, Takahashi M, Takada H, Nakayama T, Ogata K . Validation of The Individualized Neuromuscular Quality of Life in Japanese patients with myotonic dystrophy. Muscle Nerve. 2018; . DOI: 10.1002/mus.26071. View

5.
Tuikka R, Laaksonen R, Somer H . Cognitive function in myotonic dystrophy: a follow-up study. Eur Neurol. 1993; 33(6):436-41. DOI: 10.1159/000116989. View